Solid Biosciences Inc.
NASDAQ:SLDB · NASDAQ Global Select
+$0.27 today
Vol 11.08M · Avg 1.39M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+84.70%
Period High
$8.63
Period Low
$3.93
Latest
$8.33
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$851.27M
Design Therapeutics, Inc.
NASDAQ:DSGN
$761.35M
Annexon, Inc.
NASDAQ:ANNX
$586.27M
Autolus Therapeutics plc
NASDAQ:AUTL
$407.23M
Aura Biosciences, Inc.
NASDAQ:AURA
$399.32M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$350.51M
Benitec Biopharma Inc.
NASDAQ:BNTC
$314.31M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$272.37M
Quantum-Si incorporated
NASDAQ:QSI
$191.51M
What is the latest SLDB filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does SLDB have?
Intrinsic Alpha currently shows 20 recent filings for SLDB.
Explore More
Continue the stock analysis
Jump to another research area for this company.